Core Insights - The company has not developed brain-computer interface technology and equipment but is utilizing it as an auxiliary tool for its smart medical business [1] - The company aims to develop a closed-loop brain-machine interface (BMI) system based on optogenetic control to meet the needs of smart anesthesia and smart rehabilitation applications [1] Business Development - In 2022, the company established the "Brain Cognition and Smart Medical Innovation Application Laboratory" approved by Chengdu, focusing on key technologies in artificial intelligence and medical engineering [1] - The laboratory is building platforms for technology research and development, business development, and mobile application development, with plans to upgrade products in smart anesthesia assistance, IoT medical devices, integrated regional smart medical and health platforms, and rehabilitation products [1] Strategic Partnerships - The company is collaborating with the Suzhou Institute of Nano-Tech and Nano-Bionics of the Chinese Academy of Sciences to establish a brain-like intelligence and smart medical industry-university-research center [1] - This partnership aims to conduct research on key technologies and innovative applications, targeting clinical auxiliary diagnosis and treatment, clinical scientific research, and regional health and wellness applications [1] Financial Performance - In the first half of 2025, the company achieved revenue of 142 million yuan, a year-on-year decrease of 6.61% [1] - The net profit attributable to the parent company was 4 million yuan, down 24.48% year-on-year [1]

Core Viewpoint - The company is not engaged in the research and development of brain-computer interface (BCI) technology and equipment, but is utilizing BCI technology as an auxiliary tool for its smart medical business development [1] Group 1: Business Development - The company is developing a closed-loop brain-computer interface (BMI) system based on optogenetic regulation to meet the needs of smart anesthesia and smart rehabilitation applications [1] - In 2022, the company established the "Brain Cognition and Smart Medical Innovation Application Laboratory" approved by Chengdu, focusing on key technologies in artificial intelligence and medical engineering [1] Group 2: Strategic Partnerships - The company is collaborating with the Suzhou Institute of Nano-Tech and Nano-Bionics of the Chinese Academy of Sciences to build a brain-like intelligence and smart medical industry-university-research center [1] - The partnership aims to conduct research on key technologies and innovative applications, targeting clinical auxiliary diagnosis and treatment, clinical scientific research, and regional medical and health integration [1] Group 3: Product Development - The company is developing a series of products including upgraded systems for intelligent anesthesia assistance, IoT medical devices, integrated platforms for regional smart medical and health services, and upgraded rehabilitation products [1] - The focus is on creating high-end intelligent medical and rehabilitation devices, high-end wearable devices, and clinical research and auxiliary diagnosis systems and equipment as part of domestic innovation [1]